Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis
Conditions:   Eosinophilic Granulomatosis With Polyangiitis;   Churg-Strauss Syndrome Interventions:   Drug: NS-229;   Drug: Placebo Sponsors:   NS Pharma, Inc.;   Nippon Shinyaku Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials

Identification of Autoantigens in EGPA and Severe Eosinophilic Asthma
Conditions:   Churg-Strauss Syndrome;   Eosinophilic Asthma;   Eosinophilic Esophagitis;   Eosinophilic Pneumonia Intervention:   Diagnostic Test: Autoantibody ELISA Sponsor:   Queen Mary University of London Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 17, 2020 Category: Research Source Type: clinical trials